M. Haack
University of Mainz
18 Papers
3 Citations
M. Haack is an academic researcher from University of Mainz. The author has contributed to research in topics: Medicine & Prostate cancer. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Telemedicine Online Visits in Urology During the COVID-19 Pandemic-Potential, Risk Factors, and Patients' Perspective.
Katharina Boehm,Stefani Ziewers,Maximilian Peter Brandt,Peter Sparwasser,M. Haack,Franziska Willems,Anita Thomas,Robert Dotzauer,Thomas Höfner,Igor Tsaur,Axel Haferkamp,Hendrik Borgmann +11 more
TL;DR: It is concluded that many urological patients have risk factors for a poor outcome from COVID-19 and most preferred telemedicine consultations at this time, and this appears to be a solution to offer contact-free continuity of care.
195
Global change of surgical and oncological clinical practice in urology during early COVID-19 pandemic.
Robert Dotzauer,Katharina Böhm,Maximilian Peter Brandt,Peter Sparwasser,M. Haack,Sebastian Frees,Mohamed M. Kamal,Rene Mager,W. Jäger,Thomas Höfner,Igor Tsaur,Axel Haferkamp,Hendrik Borgmann +12 more
TL;DR: The COVID-19 pandemic has affected clinical practice of 93% of urologists worldwide and the impact of implementing surgical prioritization protocols with moderate cancellation rates for oncological surgeries and delay or reduction in (neo)adjuvant/palliative treatment will have to be evaluated after the pandemic.
Single-center, prospective phase 2 trial of high-intensity focused ultrasound (HIFU) in patients with unilateral localized prostate cancer: good functional results but oncologically not as safe as expected
Gregor Duwe,Katharina Boehm,M. Haack,Peter Sparwasser,Maximilian Peter Brandt,Rene Mager,Igor Tsaur,Axel Haferkamp,Thomas Höfner +8 more
TL;DR: In this paper , the authors investigated oncological follow-up and safety data of focal high-intensity focused ultrasound (HIFU) treatment for localized prostate cancer (PCa) using a single-center prospective study.
12
Smartglass augmented reality‐assisted targeted prostate biopsy using cognitive point‐of‐care fusion technology
Peter Sparwasser,M. Haack,S. Epple,Larissa Frey,S. Zeymer,Robert Dotzauer,Florian Jungmann,K. Boehm,Thomas Höfner,Igor Tsaur,Axel Haferkamp,Hendrik Borgmann +11 more
TL;DR: Augmented reality smart glasses have emerged as novel technology to support image‐guided interventions and its usage while prostate biopsy is investigated.
11
Negative multiparametric magnetic resonance imaging for prostate cancer: further outcome and consequences
M. Haack,Vanessa Miksch,Zhe Tian,Gregor Duwe,Anita Thomas,Angelika Borkowetz,Kristina Stroh,Christian Thomas,Axel Haferkamp,Thomas Höfner,Katharina Boehm +10 more
TL;DR: In this paper , the authors evaluated predictors of overall prostate cancer (PCa) in negative mpMRI and found that PCa patients had higher PSAD (0.14 vs. 0.03), total PSA level (OR 1.22 [1.01-1.47], p = 0.033), free PSA (OR 0.982 [0.15-0.91], and lower PSA density ( 0.09 vs.